A 72-year-old manwho suffered from recurrent fever was found to have enlarged bilateral adrenal glands on computed tomographic scanning, combined with subclinical adrenal insufficiency. Based on the pathology of bone marrow aspiration, he was diagnosed to have an angiotropic large cell lymphoma (ALCL). Soon after the treatment with a combination chemotherapy, he achieved complete remission ofALCLand size and function of the adrenal glands were apparently normalized. ALCLshould be included in the list of differential diagnoses of non-functioning bilateral adrenal swelling with non-specific symptoms such as fever.
Introduction
Angiotropic large cell lymphoma(ALCL), also known as intravascular lymphomatosis, is a relatively rare but fatal hematologic disorder characterized by massive proliferation of neoplastic mononuclearcells within the vascular lumen. Correct diagnosis is often difficult to make due to the non-specific symptoms, absence of tumor cells in the peripheral blood and its relatively acute clinical course. Although this disease was originally thought to be of endothelial origin (1), a consensus has now been reached that ALCLrepresents a type of malignant lymphoma (2) (3) (4) . Since clinicopathological reports of this disease, especially regarding the adrenal involvement, are limited to date, here we report a case of ALCLwith bilateral adrenal swelling presenting as partial and reversible adrenal insufficiency.
For editorial comment, see p 3.
Case Report
A 72-year-old man was admitted to our hospital on January 12, 1994, complaining of general malaise and shaking chill. For one month before admission he was recurrently febrile with an afternoon temperature around 39°C. With each episode, the fever continued for about one week and subsided spontaneously. His past medical history included malaria at 37 years of age and appendicitis at age 40. The patient' s family history was not contributory. His height was 167 cm and he weighed 57 kg; physical examination revealed the patient to be poorly nourished. His vital signs were as follows: body temperature, 39°C; pulse, 88 beats per minute (regular); and blood pressure, 90/60 mmHg.Examination of his head and neck was unremarkable. No abnormality was found in the chest or abdomen.No hepatosplenomegalyor mass wasfound in the abdomen.Surface lymph nodes were not pathognomonicand no skin lesion was found. Mental disturbance such as hallucination and confusion were episodically observed even during the period when he was not febrile, but other neurological abnormalities were not noted. Urinalysis was negative. A complete blood count revealed anemia (hematocrit; 27.8%, hemoglobin; 9.5 g/dl) and thrombocytopenia (105,000/jal).
White blood cell count was 3,900/mm3 with a normal hemogram. Prothrombin time (PT) was 12.0 seconds, and activated partial thromboplastin time (APTT) was 35.3 seconds with a control of28.2 seconds. Serum fibrinogen and fibrin degradation products (FDP) levels were 3 14 mg/dl and 9. 8 Jig/ml, respectively, and the antithrombin-III level was 66%. Liver function tests were also within normal limits. The serum lactic dehydrogenase (LDH) level was el- (PRA)were quantitated by radioimmunoassay(RIA), using commercialkits. Hormonelevels determinedusing plasma obtained at 9 AMafter lh of recumbentposition are shownin Table 1 . Theserumcortisol level showedan inadequately low cortisol response from 1 1.8 \ig/&\ to 14.4 |Lig/dl at 60 minutes after iv injection of 0.25 \xg synthetic ACTH. Amongthe plasmacatecholamines,the adrenaline level quantitated similarly in the morningwasabnormallylow at less than 5 pg/ml, butthoseof noradrenaline anddopamine werewithinnormal limits. Abone marrowbiopsy revealed hypocellular marrow with large immature lymphoid cells infiltrating and filling the small blood vessels (Fig. 2) . Immunohistologically, the abnormal cells showedpositive staining to B-cell markers such as LCA,L26, and LN2, indicating the cells to be of B-cell originated ALCL.
Thepatient received a regimenof chemotherapy termed modified CHOPwith cyclophosphamide (840 mg/day x 1 day), doxorubicin HC1(56 mg/day x 1 day), vincristine (1.5 mg/day x 1 day), and prednisolone (70 mg/day x 5 days). After receiving 6 cycles of the regimen over 4 months, the patient became free fromthe symptoms andlymphoma cells wereundetectable in the bone marrowspecimen. In the laboratory findings, LDH level wasnormalizedafter the first cycle of the regimenand plasma ACTHand serumcortisol levels measuredin the morningwerenormalwhenmeasuredfour monthslater at 1 17 pg/ml and 12.8 jag/dl, respectively (Table 1) . Plasma aldosteroneandrenin activity werewithinnormallimits andserum ALCLwith Reversible Adrenal Insufficiency sodium, chloride, and potassium levels were 141, 106, and 4. 1 mmol//, respectively. Adrenal imaging on CT scan also became apparently normal (Fig. IB) .
Discussion
ALCLis a rare and distinctive form of non-Hodgkin lymphomacharacterized by proliferated malignant lymphoid cells within the vascular lumina (4). As a non-Hodgkin lymphoma, ALCLis still a lethal disorder at present which is frequently difficult to recognize with an accurate antemortemdiagnosis due to the lack of characteristic symptoms and non-specific laboratory data such as high serum LDHlevels. Malignant cells are rarely found in the peripheral blood specimen. In this unusual disorder, however, the lymphoma cells are frequently distributed within the small vessels of systemic organs causing characteristically regional features such as changes of the mental status and skin lesions. Here wepresented a typical case of ALCLwhich has been successfully treated.
The patient was first characterized with the massive bilateral adrenal involvement of ALCL lymphomacells. In addition to brain and skin, adrenal glands have also been reported to be frequently invaded by the ALCLtumor cell and present as gross tumors. Kayano and Katayama (5) counted the lymphomatous mass lesions in 33 out of 103 ALCLcases reviewed, and found that 17 cases (52%) among the 33 had adrenal involvement, the highest incidence among all of the organs listed; incidentally, the numberof both brain and skin lesions was only 2 in this series. In their report it is also impressive that 16 out of 17 adrenal involvements were bilateral. Later Usuda and his colleagues (5) also collected 109 reported autopsies of ALCLand found that out of 19 cases with gross tumors, 13 cases (68%) had tumors in the adrenal glands and among them, 62% were bilateral. Thus, frequent bilateral involvement of the adrenal glands maybe a unique feature of ALCL(6). Meanwhile, it has been generally recognized that adrenal lymphomais rare; in review of more than 1,400 cases with extra-nodal lymphomas, adrenal involvement was reported to be less than 0.2% (7). Recently, however, adrenal enlargement has become easily detectable due to the development and popularization of diagnostic imaging techniques such as echography, computed tomography, and magnetic resonance imaging. Adrenal incidentalomas found in this way consist of a variety of etiologies (8), and whenthe adrenals are not endocrinologically activated, it still may not be easily diagnosed properly (9, 10) . Considering its unique clinical characteristics, we suggest that, in addition to primary adrenal lymphomas ( 1 1 ), ALCLshould be included in the list of differential diagnoses of the adrenal incidentaloma, especially for patients with non-functioning bilateral adrenal enlargement.
Here, chemotherapy was quite effective for the patient including improvement of the impaired adrenal function. Before the start of the chemotherapy, he showed a high basal ACTHwith normal cortisol levels and the cortisol level did not increase sufficiently to the exogenous ACTHinjection. These data suggested that his endogenous ACTH secretion was stimulated to overcome the disabled cortisol synthesis. The slightly low serum sodium concentration and the high PRAwith a normal aldosterone level indicated that the aldosterone synthesis was also insufficient in the patient's adrenal glands. These data taken together with the lack of apparent clinical signs and symptomsofAddison' s disease, we assessed the adrenocortical function to be in stage 3 ofhypocortisolism, which is one stage before the clinically overt Addison's disease (12, 13). The decreased plasma adrenaline level suggested that the adrenal medulla was considerably involved bilaterally. These dysfunctions apparently recovered after the chemotherapy along with the other clinical improvement. Adrenal dysfunction shown in this patient might be due to reversible damage such as regional ischemia caused by intravascular aggregation of the tumor cells.
ALCLis to date a fatal disorder which is difficult to diagnose during the premortem period. Since the establishment of the lymphoid nature of this disease, however, several types of chemotherapy have been tried in accordance with the regimen for malignant lymphomasand have been proven to be effective to improve the clinical course of ALCL.Therefore, ALCL should be diagnosed at as early a stage as possible to start the chemotherapy. Indeed, other than the present case, only one case has been reported in which ALCLwith adrenal involvement was diagnosed while alive and chemotherapy was effective for recovery of the adrenal function (14) . ALCL has definitely been underestimated as a disorder which causes adrenal incidentalomas. Whenever a patient with non-specific symptomssuch as fever of unknownorigin has enlarged adrenal glands, ALCLshould be considered even if the patient has neither brain nor skin lesions. Diagnosis during the early stage of ALCLmaymake chemotherapy clinically effective even for this lethal disorder.
